COVID-19 Treatments

and Neutralising Monoclonal

Antibodies – An Update


Dr Mike Stephens to Host live Q&A update on the latest COVID treatments including neutralising monoclonal antibodies.


Late in 2021 we learned that there would be new treatments available to those most vulnerable to COVID-19 as an addition to vaccinations. The vaccinations remain the best way to protect ourselves against this virus, however, with the news of the Neutralising Monoclonal Antibody treatments (nMAb) it is understandable that questions arise around it.


Live Q&A for patients and families

6pm, Tuesday 25 Jan 2022

Kidney Wales Community Facebook Group


The new antiviral and antibody treatments for Covid-19 are available for people aged 12 and over who have a positive PCR test for the virus and are at highest risk of getting seriously ill. A doctor or specialist will confirm if you are eligible for treatment. The eligible groups of kidney patients entitled to be considered for the new treatments include:


  • Those who have received B cell depleting-therapies or equivalent immunosuppression (eg rituximab)
  • Had an organ transplant or equivalent immunosuppression (eg immune-mediated kidney disease)
  • All CKD 4 and 5 patients, including those on dialysis


We’re grateful to have Dr Mike Stephens, Consultant Transplant Surgeon and Kidney Wales trustee joining us again to answer your questions and offer his expertise.


You are invited to tune into our Q&A session for answers and reassurance. Submit your questions prior to the session to ensure you are getting the information and answers you need.


Are you concerned about the availability of treatments? Or of the delays to the introduction of home PCR testing kits in Wales? We want to help alleviate concerns and offer a safe space for open conversation with an expert in this area.


Please submit your questions to us by 10PM Sunday 23rd January, using the form below.


We hope you can join us!